Works about FLUTICASONE propionate

Results: 322

Optinose Xhance approved by FDA as first medical therapy for CRS.

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

TGIF for Optinose Xhance: PDUFA Date is 3-16-2024 for First Medical Therapy for CRS.

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

Two Cases of Surreptitious Steroid Use Uncovered Utilizing Urine Synthetic Glucocorticoid Testing.

Published in:

JCEM Case Reports, 2023, v. 1, n. 6, p. 1, doi. 10.1210/jcemcr/luad132

By:

Pape, Bryn J;
Kern, Philip A

Publication type:

Article

LABAs and p38MAPK Inhibitors Reverse the Corticosteroid-Insensitivity of IL-8 in Airway Smooth Muscle Cells of COPD.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 12, p. 2058, doi. 10.3390/jcm8122058

By:

Knobloch, Jürgen;
Jungck, David;
Kronsbein, Juliane;
Stoelben, Erich;
Ito, Kazuhiro;
Koch, Andrea

Publication type:

Article

An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel.

Published in:

NPJ Primary Care Respiratory Medicine, 2017, p. 1, doi. 10.1038/s41533-016-0001-y

By:

Lipworth, Brian;
Newton, Jon;
Ram, Bhaskar;
Small, Iain;
Schwarze, Jürgen

Publication type:

Article

The effect of umeclidinium added to inhaled corticosteroid/long-acting β<sub>2</sub>-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study.

Published in:

NPJ Primary Care Respiratory Medicine, 2016, p. 16031, doi. 10.1038/npjpcrm.2016.31

By:

Sousa, Ana R;
Riley, John H;
Church, Alison;
Zhu, Chang-Qing;
Punekar, Yogesh S;
Fahy, William A

Publication type:

Article

The efficiency of azelastine hydrochloride and fluticasone propionate nasal spray to improve PAP adherence in patients with obstructive sleep apnea.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-99548-x

By:

Wongchan, Rachata;
Tepwimonpetkun, Chatkarin;
Kitsongsermthon, Jutarat;
Sapankaew, Tunlanut;
Yotsombut, Kitiyot;
Chittiwan, Weasarath

Publication type:

Article

Validated HPLC method for simultaneous determination of azelastine hydrochloride fluticasone propionate and oxymetazoline in nasal mucosa and nasopharyngeal swabs from real human samples.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-024-82387-7

By:

Mikawy, Neven N.;
Magdy, Nancy;
Mohamed, Marwa H.;
El-Kosasy, Amira M.

Publication type:

Article

Comparative Study of Topical Treatment in Allergic Rhinitis Using Azelastine and Fluticasone in a Combination Verses Fluticasone Propionate Alone.

Published in:

Journal of Krishna Institute of Medical Sciences (JKIMSU), 2019, v. 8, n. 2, p. 21

By:

Dalvi, Raisha G.;
Havle, Abhay D.;
Khairmode, Ganesh S.;
Vihapure, Ganesh M.;
Shedge, Swapna A.

Publication type:

Article

What makes flunisolide different among inhaled corticosteroids used for nebulization: a close look at the role of aqueous solubility.

Published in:

Multidisciplinary Respiratory Medicine, 2021, v. 16, p. 1, doi. 10.4081/mrm.2021.719

By:

Kantar, Ahmad

Publication type:

Article

Pharmacokinetics and Bioequivalence of 2 Products of Fluticasone Propionate Nasal Spray in Healthy Chinese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 5, p. 398, doi. 10.1002/cpdd.1507

By:

Wang, Pengkai;
Li, Yuan;
Xu, Bing;
Zhang, Ping;
Cui, Chang;
Li, Xin

Publication type:

Article

Safety, tolerability, pharmacokinetics, and pharmacodynamics of compound SFDAC by intranasal administration of multiple escalating dose in healthy male subjects.

Published in:

Clinical Pharmacology in Drug Development, 2014, v. 3, n. 6, p. 428, doi. 10.1002/cpdd.136

By:

Thennati, Rajamannar;
Khanna, Aman;
Khanna, Mallika;
Sonaiya, Tushar;
Mehta, Tejas;
Mehta, Kalpana;
Shahi, Pradeep;
Patel, Jigneshkumar

Publication type:

Article

Pharmacokinetics and pharmacodynamics of GSK961081, a novel inhaled muscarinic antagonist β<sub>2</sub>-agonist, and fluticasone propionate administered alone, concurrently and as a combination blend formulation in healthy volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2014, v. 3, n. 4, p. 305, doi. 10.1002/cpdd.105

By:

Norris, Virginia;
Ambery, Claire;
Riley, Trevor

Publication type:

Article

Bioequivalence study of fluticasone propionate nebuliser suspensions in healthy Chinese subjects.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2024.1452596

By:

Cheng, Feng;
Shen, Tao;
Zhang, Fucheng;
Lei, Chenghao;
Zhu, Ye;
Luo, GuoJun;
Xiao, Dawei

Publication type:

Article

Transcriptomic Expression of T2-Inflammation Genes in Peripheral Blood Mononuclear Cells and Longitudinal Clinical Outcomes in Asthma: Insights from the COREA Study.

Published in:

Lung (0341-2040), 2024, v. 202, n. 4, p. 449, doi. 10.1007/s00408-024-00728-9

By:

Pham, Duong Duc;
Shin, Eunsoon;
Lee, Jong Eun;
Lee, Ji-Hyang;
Song, Woo-Jung;
Kwon, Hyouk-Soo;
Cho, You Sook;
Won, Sungho;
Kim, Tae-Bum

Publication type:

Article

Comparative Meta-Analysis of the Efficacy of Once-Daily Fluticasone Furoate 100 µG Versus Twice-Daily Fluticasone Propionate 250 µG in Adolescents and Adults with Persistent Asthma.

Published in:

2017

By:

Tomlinson, Ryan;
Parks, Daniel;
Martin, Alan

Publication type:

Report

Addition of oral fexofenadine to topical therapy leads to a significantly greater reduction in the serum interleukin‐31 levels in mild to moderate paediatric atopic dermatitis.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 4, p. 724, doi. 10.1111/ced.15032

By:

Ningombam, A.;
Handa, S.;
Srivastava, N.;
Mahajan, R.;
De, D.

Publication type:

Article

Normalisation of airflow limitation in asthma: Post‐hoc analyses of TRIMARAN and TRIGGER.

Published in:

Clinical & Translational Allergy, 2022, v. 12, n. 4, p. 1, doi. 10.1002/clt2.12145

By:

Papi, Alberto;
Singh, Dave;
Virchow, J. Christian;
Canonica, G. Walter;
Vele, Andrea;
Georges, George

Publication type:

Article

Retracted: Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD).

Published in:

2024

By:

International, Emergency Medicine

Publication type:

Correction Notice

Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD).

Published in:

Emergency Medicine International, 2022, p. 1, doi. 10.1155/2022/2593740

By:

Mills, Hilla;
Acquah, Ronald;
Tang, Nova;
Cheung, Luke;
Klenk, Susanne;
Glassen, Ronald;
Pirson, Magali;
Albert, Alain;
Hoang, Duong Trinh;
Van, Thang Nguyen

Publication type:

Article

Efficacy of intranasal fluticasone propionate nano nasal spray in management of chronic rhinitis: a randomized clinical trial.

Published in:

Italian Journal of Medicine, 2022, v. 16, n. 1, p. 49, doi. 10.4081/itjm.2022.1545

By:

Mehmood, Yasir;
Shahid, Hira

Publication type:

Article

Comparing Budesonide and Fluticasone Propionate in Children with Moderate to Severe Asthma: A Pilot Randomized Controlled Trial.

Published in:

Iranian Journal of Allergy, Asthma & Immunology, 2023, v. 22, n. 6, p. 527, doi. 10.18502/ijaai.v22i6.14642

By:

Sadeghzadeh, Mansour;
Khoshnevisasl, Parisa;
Ahmadiafshar, Akefeh;
Motamed, Nima;
Pourmarjani, Azadeh

Publication type:

Article

Recognition of Inhaled Corticosteroids or Leukotriene Inhibitors as Controller Medications Among Older Adults and Its Association with Asthma Controller Medication Adherence.

Published in:

2019

By:

McInerney, Grace E.;
O'Conor, Rachel;
Wolf, Michael S.;
Wisnivesky, Juan P.;
Federman, Alex D.

Publication type:

journal article

Nasal Steroids Use in the Prevention of Symptomatizing Adenoid Regrowth after Adenoidectomy.

Published in:

QJM: An International Journal of Medicine, 2021, v. 114, p. i111, doi. 10.1093/qjmed/hcab094.008

By:

Ezzat, Waleed F.;
Abo Elczz, Tamer A.;
Marouf, Ahmed M.;
Ahmed, Eman M.

Publication type:

Article

DrugWAS: Drug‐wide Association Studies for COVID‐19 Drug Repurposing.

Published in:

Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 6, p. 1537, doi. 10.1002/cpt.2376

By:

Bejan, Cosmin A.;
Cahill, Katherine N.;
Staso, Patrick J.;
Choi, Leena;
Peterson, Josh F.;
Phillips, Elizabeth J.

Publication type:

Article

No exacerbation but impaired anti-viral mechanisms in a rhinovirus-chronic allergic asthma mouse model.

Published in:

Clinical Science, 2014, v. 126, n. 1, p. 55, doi. 10.1042/CS20130174

By:

ROCHLITZER, Sabine;
HOYMANN, Heinz-Gerd;
MÜLLER, Meike;
BRAUN, Armin

Publication type:

Article

An efficacy and safety evaluation of montelukast + fluticasone propionate vs. fluticasone propionate in the treatment of cough variant asthma in children: a meta-analysis.

Published in:

BMC Pulmonary Medicine, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12890-023-02721-z

By:

Wei, Zhengbo;
Li, Sheng

Publication type:

Article

The clinical efficacy of fluticasone propionate combined with ACEI/ARB in the treatment of immunoglobulin A nephropathy.

Published in:

BMC Nephrology, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12882-023-03106-4

By:

Sun, Liping;
Zi, Xinyi;
Wang, Zhen;
Zhang, Xinzhou

Publication type:

Article

A Retrospective Study Evaluating Asthma Control in Patients on Fluticasone Propionate/Salmeterol Proactive Regular Dosing with a History of Uncontrolled Asthma.

Published in:

Pulmonary Therapy, 2025, v. 11, n. 1, p. 25, doi. 10.1007/s41030-024-00278-8

By:

Ismail, Ahmad Izuanuddin;
Hyder Ali, Irfhan Ali;
Wong, Chee Kuan;
Ban, Andrea Yu-Lin;
MZ Zahrah, Fatimah;
Lem, Li Khen;
Abu Bakar, Zamzurina;
Alaga, Arvindran;
Omar, Azza;
Samsudin, Azlina;
Lai, Siew Li;
Gandhi, Alap

Publication type:

Article

Correction: A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis.

Published in:

2024

By:

Zhou, Bing;
Cheng, Lei;
Pan, Jing;
Wang, Huizhong;
Jin, Yongde;
Zhao, Changqing;
Lin, Peng;
Tan, Guolin;
Fang, Hongyan;
Zhang, Hua;
Zhou, Huifang;
Dong, Yaowu;
Kuhl, Hans Christian;
Ramalingam, Rajesh Kumar;
Nguyen, Duc Tung

Publication type:

Correction Notice

A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis.

Published in:

Pulmonary Therapy, 2023, v. 9, n. 3, p. 411, doi. 10.1007/s41030-023-00238-8

By:

Zhou, Bing;
Cheng, Lei;
Pan, Jing;
Wang, Huizhong;
Jin, Yongde;
Zhao, Changqing;
Lin, Peng;
Tan, Guolin;
Fang, Hongyan;
Zhang, Hua;
Zhou, Huifang;
Dong, Yaowu;
Kuhl, Hans Christian;
Ramalingam, Rajesh Kumar;
Nguyen, Duc Tung

Publication type:

Article

Wixela Inhub: A Generic Equivalent Treatment Option for Patients with Asthma or COPD.

Published in:

Pulmonary Therapy, 2021, v. 7, n. 1, p. 47, doi. 10.1007/s41030-020-00142-5

By:

Donohue, James F.;
Burgoyne, Douglas S.;
Ward, Jonathan K.;
Allan, Richard;
Koltun, Arkady;
Cooper, Andrew

Publication type:

Article

Patients with Asthma Prescribed Once-Daily Fluticasone Furoate/Vilanterol or Twice-Daily Fluticasone Propionate/Salmeterol as Maintenance Treatment: Analysis from a Claims Database.

Published in:

Pulmonary Therapy, 2018, v. 4, n. 2, p. 135, doi. 10.1007/s41030-018-0084-4

By:

Atsuta, Ryo;
Takai, Jun;
Mukai, Isao;
Kobayashi, Akihiro;
Ishii, Takeo;
Svedsater, Henrik

Publication type:

Article

Evaluation of Rapid Onset of Action of ICS/LABA Combination Therapies on Respiratory Function in Asthma Patients: A Single-Center, Open-Label, Randomized, Crossover Trial.

Published in:

Pulmonary Therapy, 2018, v. 4, n. 2, p. 159, doi. 10.1007/s41030-018-0062-x

By:

Ohbayashi, Hiroyuki;
Kudo, Sahori;
Ariga, Mitsue

Publication type:

Article

And Then There Were Three: Time to Move Onward in COPD Drug Development Beyond LAMA/LABA/ICS at Last?

Published in:

Pulmonary Therapy, 2018, v. 4, n. 2, p. 115, doi. 10.1007/s41030-018-0059-5

By:

Beeh, Kai M.

Publication type:

Article

Economic Evaluation of Fluticasone Propionate/Formoterol (Flutiform) vs. Fluticasone/Salmeterol and Budesonide/Formoterol in Spain.

Published in:

Pulmonary Therapy, 2016, v. 2, n. 2, p. 199, doi. 10.1007/s41030-016-0021-3

By:

Moragón, Eva;
Delgado, Julio;
Ojeda, Pedro;
Llano, Luis;
Collar, Juan;
Antón-Rodriguez, Cristina;
Martín-Saborido, Carlos

Publication type:

Article

Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta Agonists for Patients with COPD: Pooled Results of Randomized Placebo-Controlled Trials.

Published in:

Pulmonary Therapy, 2016, v. 2, n. 1, p. 43, doi. 10.1007/s41030-016-0012-4

By:

Siler, Thomas;
Kerwin, Edward;
Tombs, Lee;
Fahy, William;
Naya, Ian

Publication type:

Article

Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta-Agonist.

Published in:

Pulmonary Therapy, 2016, v. 2, n. 1, p. 73, doi. 10.1007/s41030-016-0014-2

By:

Roche, Nicolas;
Colice, Gene;
Israel, Elliot;
Martin, Richard;
Dorinsky, Paul;
Postma, Dirkje;
Guilbert, Theresa;
Grigg, Jonathan;
Aalderen, Willem;
Barion, Francesca;
Hillyer, Elizabeth;
Thomas, Victoria;
Burden, Anne;
Brett McQueen, R.;
Price, David

Publication type:

Article

An Integrated Analysis of Fluticasone Furoate/Vilanterol (FF/VI) Versus FF Safety Data Across Phase II and III Asthma Studies.

Published in:

Pulmonary Therapy, 2016, v. 2, n. 1, p. 91, doi. 10.1007/s41030-016-0015-1

By:

Busse, William;
Andersen, Leslie;
Frith, Lucy;
Harvey, Catherine;
Jacques, Loretta

Publication type:

Article

Investigational Treatments in Phase I and II Clinical Trials: A Systematic Review in Asthma.

Published in:

Biomedicines, 2022, v. 10, n. 9, p. 2330, doi. 10.3390/biomedicines10092330

By:

Calzetta, Luigino;
Aiello, Marina;
Frizzelli, Annalisa;
Pistocchini, Elena;
Ritondo, Beatrice Ludovica;
Rogliani, Paola;
Chetta, Alfredo

Publication type:

Article

miR-22-3p 通过激活 PTEN/PI3K/AKT/NF-кB 信号通路加重慢性阻塞性肺疾病.

Published in:

Progress in Modern Biomedicine, 2023, v. 23, n. 10, p. 1835, doi. 10.13241/j.cnki.pmb.2023.10.006

By:

白莉敏;
吕行;
任引刚;
祝松涛;
杨璐

Publication type:

Article

基于 TGF-β1-Smad2 信号通路探讨布地奈德对高氧诱导支气管肺发育不良新生小鼠的保护作用及机制研究.

Published in:

Progress in Modern Biomedicine, 2021, v. 21, n. 20, p. 3823, doi. 10.13241/j.cnki.pmb.2021.20.005

By:

李妙晨;
卞相丽;
郑芳;
蒋芹;
吴志敏

Publication type:

Article

Efficacy of treatment with montelukast, fluticasone propionate and budesonide liquid suspension for the prevention of recurrent asthma paroxysms in children with wheezing disorders.

Published in:

Experimental & Therapeutic Medicine, 2019, v. 18, n. 4, p. 3090, doi. 10.3892/etm.2019.7894

By:

Ding, Bo;
Lu, Yanming;
Li, Yaqin;
Zhou, Wenjing;
Qin, Feng

Publication type:

Article

Preclinical evaluation of novel synthesised nanoparticles based on tyrosine poly(ester amide) for improved targeted pulmonary delivery.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-59588-1

By:

Dahmash, Eman Zmaily;
Achkar, Nour Radwan;
Ali, Dalia Khalil;
Jarrar, Qais;
Iyire, Affiong;
Assaf, Shereen M.;
Alyami, Hamad

Publication type:

Article

CycloZ Suppresses TLR4-Driven Inflammation to Reduce Asthma-Like Responses in HDM-Exposed Mouse Models.

Published in:

Cells (2073-4409), 2024, v. 13, n. 23, p. 2034, doi. 10.3390/cells13232034

By:

Lee, Dohyun;
Jeon, Jongsu;
Baek, Seoyeong;
Park, Onyu;
Kim, Ah-Ram;
Do, Myoung-Sool;
Jung, Hoe-Yune

Publication type:

Article

Fluticasone Propionate Suppresses Poly(I:C)-Induced ACE2 in Primary Human Nasal Epithelial Cells.

Published in:

Frontiers in Cellular & Infection Microbiology, 2021, v. 11, p. N.PAG, doi. 10.3389/fcimb.2021.655666

By:

Nakazono, Akira;
Nakamaru, Yuji;
Ramezanpour, Mahnaz;
Kondo, Takeshi;
Watanabe, Masashi;
Hatakeyama, Shigetsugu;
Kimura, Shogo;
Honma, Aya;
Wormald, P. J.;
Vreugde, Sarah;
Suzuki, Masanobu;
Homma, Akihiro

Publication type:

Article

Editorial: fluticasone propionate orally disintegrating tablets—interesting concept but is it going anywhere? Authors' reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 10, p. 990, doi. 10.1111/apt.15713

By:

Hirano, Ikuo;
Safroneeva, Ekaterina;
Roumet, Marie C.;
Comer, Gail M.;
Eagle, Gina;
Schoepfer, Alain;
Falk, Gary W.

Publication type:

Article

Editorial: fluticasone propionate orally disintegrating tablets—interesting concept but is it going anywhere?

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 10, p. 989, doi. 10.1111/apt.15694

By:

Richter, Joel E.

Publication type:

Article

Randomised clinical trial: the safety and tolerability of fluticasone propionate orally disintegrating tablets versus placebo for eosinophilic oesophagitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 8, p. 750, doi. 10.1111/apt.15670

By:

Hirano, Ikuo;
Safroneeva, Ekaterina;
Roumet, Marie C.;
Comer, Gail M.;
Eagle, Gina;
Schoepfer, Alain;
Falk, Gary W.

Publication type:

Article

Letter: reassuringly normal response to ACTH in children treated with swallowed topical corticosteroids for eosinophilic oesophagitis.

Published in:

2019

By:

Rodríguez Manchón, Silvia;
Domínguez Ortega, Gloria;
Bacelo Ruano, Irene;
Martínez Ibeas, María Angeles;
Pozo Román, Jesús;
Cañedo Villarroya, Elvira;
Muñoz Codoceo, Rosa Ana

Publication type:

Letter to the Editor